News

Kala said Crown Venture Fund is the new and lead investor who joined its existing investors including Lux Capital Management, Polaris Venture Partners and Third Rock Ventures. The

Under the alliance, M*Modal will serve its M*Modal Catalyst analytics platform and the Claro Group will provide its consulting services to the physicians and healthcare professionals, which can

The firm’s new MPI solution with its cloud-based foundation identifies customer identifiers, which further help to decrease the number of duplicates and overlays found within a single organization.

The firm’s new platform is created to improve deployment and integration, and reduce infrastructure investments for adoption of BIandanalytics tools by healthcare organizations. In addition, BI-Clinical has developed

The patent entitled, ‘In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages,’ expands the DPC platform, broadly protecting the company’s next generation DPC polymer masking technology. The company

According to the firm, the design of the facility will allow a very high degree of customization of the production process. The facility is expected to enable cGMP

AbsoluteIDQ p150 provides metabolic information from a single targeted assay, quantifying 158 metabolites using a FIA-MS/MS method. The kit is infused with Biocrates proprietary MetIDQ software, which requires

The firm’s expansion plan includes three additional cGMP manufacturing facilities, a new automated packaging line and further drug product and cold storage. The new facility is designed to

The company claims that the new Macofar LF 200 liquid filler was developed in response to the sector’s growing demand for high-speed machines. The technology is suited for